Submitted by Anonymous (not verified) on 28 March 2025 - 13:05
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 14, Status: Authorised
Source: